Transdermal drug delivery devices having coated microprotrusions

• US 7,537,795 B2
• Filed: 10/26/2001
• Issued: 05/26/2009
• Est. Priority Date: 10/26/2000
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Nyam, Kofi, Daddona, Peter E., Young, Wendy A., Cormier, Michel J. N.
• Primary Examiner(s): CAMERON, ERMA C
• Application Number:
  US10/045,842
• Publication Number:
  US 20020128599A1
• Time in Patent Office: 2,769 Days
• Field of Search: 427/2.31
• US Class Current: 427/2.28
• CPC Class Codes: A61K 9/0021 Intradermal administration, e.g. through microneedle arrays, needleless injectors mechanical aspects A61M
• CPC Class Codes: A61M 2037/0023 Drug applicators using microneedles
• CPC Class Codes: A61M 2037/003 having a lumen
• CPC Class Codes: A61M 2037/0046 Solid microneedles
• CPC Class Codes: A61M 2037/0061 Methods for using microneedles
• CPC Class Codes: A61M 37/0015 by using microneedles

Abstract

A device (12) and method are provided for percutaneous transdermal delivery of a potent pharmacologically active agent. The agent is dissolved in water to form an aqueous coating solution having an appropriate viscosity for coating extremely tiny skin piercing elements (10). The coating solution is applied to the skin piercing elements (10) using known coating techniques and then dried. The device (12) is applied to the skin of a living animal (e.g., a human), causing the microprotrusions (10) to pierce the stratum corneum and deliver a therapeutically effect dose of the agent to the animal.

Claims

1. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises;

and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

2. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto said microprotrusions; and

drying said applied aqueous solution to form a dry agent-containing coating on said microprotrusions, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

3. The method of claim 2, wherein the coating provides systemic delivery of about 25% to 50% of the agent upon application of the device to the skin of a subject for 5 seconds and wherein the agent comprises desmopressin or hGH.

4. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

said microprotrusions adapted to pierce through the stratum corneum to a depth of less than about 500 micrometers;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

5. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions, said microprotrusions having a length of less than 500 micrometers and a thickness of less than 25 micrometers;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

6. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member;

said pharmacologically active agent selected from the group consisting of adrenocorticotropic hormone (ACTH (1-24)), calcitonin, desmopressin, leutinizing hormone releasing hormone (LHRH), goserelin, leuprolide, buserelin, triptorelin, parathyroid hormone (PTH), vasopressin, deamino [Val4, D-Arg8] arginine vasopressin, interferon alpha, interferon beta, interferon gamma, follicle stimulating hormone (FSH), erythoropoietin (EPO), granulocyte macrophage colony stimulating factor (GM-CSF), granulocyte colony stimulating factor (G-CSF), interleukin-10 (IL-10), glucagon, and growth regulatory factor (GRF); and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

7. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent desmopressin onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

8. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratus corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

9. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein said agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 50 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

10. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member;

said coating having a thickness over a surface of said member of less than 50 micrometers;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

11. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member;

said coating having a thickness over a surface of said member of less than 25 micrometers;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

12. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

providing an aqueous solution comprising said pharmacologically active agent and an adjuvant;

applying said aqueous solution onto the member; and

drying said applied aqueous solution to form a dry agent-containing and adjuvant-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

13. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member;

said coating comprising a loading of said pharmacologically active agent of less than 1 mg/cm² of area of said member, and said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

14. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto the member; and

drying said applied aqueous solution to form a dry agent-containing coating on said member;

said coating comprising a loading of said pharmacologically active agent of less than 0.5 mg/cm² of area of said member, and said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1 mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said agent having an aqueous solution having a viscosity at about 25°

C. less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.

15. A method of making a device for transdermally delivering a pharmacologically active agent, the method comprising:

providing a member having a plurality of stratum corneum-piercing microprotrusions;

applying an aqueous solution of the pharmacologically active agent onto said member by dip coating said member in said solution; and

drying said applied aqueous solution to form a dry agent-containing coating on said member, said coating being less than a thickness of the microprotrusions;

wherein the agent is sufficiently potent to be therapeutically effective when administered in an amount of less than about 1mg, said agent having an aqueous solubility at about 25°

C. of greater than about 50 mg/ml and said aqueous solution having a viscosity at about 25°

C. of less than about 500 centipoises; and

wherein the method provides uniformity of coating from microprotrusion to microprotrusion.